Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.2 USD | +4.61% | -9.50% | -15.41% |
Financials (USD)
Sales 2024 * | 2.72B | Sales 2025 * | 3.04B | Capitalization | 10.45B |
---|---|---|---|---|---|
Net income 2024 * | 449M | Net income 2025 * | 549M | EV / Sales 2024 * | 3.3 x |
Net cash position 2024 * | 1.46B | Net cash position 2025 * | 2.25B | EV / Sales 2025 * | 2.69 x |
P/E ratio 2024 * |
23.7
x | P/E ratio 2025 * |
18.4
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
1 day | -5.34% | ||
1 week | -14.99% | ||
Current month | -11.87% | ||
1 month | -26.96% | ||
3 months | -32.31% | ||
6 months | -18.95% | ||
Current year | -18.91% |
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 14-04-29 |
Darren Rushworth
PSD | President | 56 | 16-12-31 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 16-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 13-07-31 |
David Kostman
CHM | Chairman | 59 | 00-12-31 |
Dan Falk
BRD | Director/Board Member | 79 | 00-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.31% | 16 M€ | +2.01% | ||
0.60% | 2 M€ | +24.97% | ||
0.28% | 7 M€ | -.--% | - | |
0.16% | 20 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 168.8 | +4.32% | 914 629 |
24-06-05 | 161.8 | -5.34% | 3,101,878 |
24-06-04 | 170.9 | -4.19% | 2,104,214 |
24-06-03 | 178.4 | -2.83% | 831,577 |
24-05-31 | 183.6 | -1.56% | 777,655 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.76% | 3,151B | |
+14.22% | 90.11B | |
+8.83% | 81.27B | |
-15.04% | 53.72B | |
+33.72% | 51.13B | |
+35.37% | 47.65B | |
-33.62% | 41.1B | |
+75.63% | 40.85B | |
+4.03% | 28.7B |
- Stock Market
- Equities
- NICE Stock
- NICE Stock